The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Opioids-Global Market Insights and Sales Trends 2025
Synopsis
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global Opioids market size is expected to reach US$ 14730 million by 2029, growing at a CAGR of 5.5% from 2023 to 2029. The market is mainly driven by the significant applications of Opioids in various end use industries. The expanding demands from the Pain Relief, Anesthesia, Cough Suppression and Diarrhea Suppression, are propelling Opioids market. Oxycodone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hydromorphone segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Opioids, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Opioids market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Opioids market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Opioids sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Opioids covered in this report include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer and INSYS, etc.
The global Opioids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Global Opioids market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Opioids market, Segment by Type:
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Global Opioids market, by Application
Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Opioids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Opioids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global Opioids market size is expected to reach US$ 14730 million by 2029, growing at a CAGR of 5.5% from 2023 to 2029. The market is mainly driven by the significant applications of Opioids in various end use industries. The expanding demands from the Pain Relief, Anesthesia, Cough Suppression and Diarrhea Suppression, are propelling Opioids market. Oxycodone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hydromorphone segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Opioids, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Opioids market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Opioids market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Opioids sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Opioids covered in this report include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer and INSYS, etc.
The global Opioids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Global Opioids market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Opioids market, Segment by Type:
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Global Opioids market, by Application
Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Opioids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Opioids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Opioids Market Overview
1.1 Opioids Product Overview
1.2 Opioids Market Segment by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Other
1.3 Global Opioids Market Size by Type
1.3.1 Global Opioids Market Size Overview by Type (2018-2029)
1.3.2 Global Opioids Historic Market Size Review by Type (2018-2023)
1.3.3 Global Opioids Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioids Sales Breakdown by Type (2018-2023)
1.4.2 Europe Opioids Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Opioids Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Opioids Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Opioids Sales Breakdown by Type (2018-2023)
2 Global Opioids Market Competition by Company
2.1 Global Top Players by Opioids Sales (2018-2023)
2.2 Global Top Players by Opioids Revenue (2018-2023)
2.3 Global Top Players by Opioids Price (2018-2023)
2.4 Global Top Manufacturers Opioids Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioids Market Competitive Situation and Trends
2.5.1 Opioids Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioids Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids as of 2022)
2.7 Date of Key Manufacturers Enter into Opioids Market
2.8 Key Manufacturers Opioids Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioids Status and Outlook by Region
3.1 Global Opioids Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Opioids Historic Market Size by Region
3.2.1 Global Opioids Sales in Volume by Region (2018-2023)
3.2.2 Global Opioids Sales in Value by Region (2018-2023)
3.2.3 Global Opioids Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Opioids Forecasted Market Size by Region
3.3.1 Global Opioids Sales in Volume by Region (2024-2029)
3.3.2 Global Opioids Sales in Value by Region (2024-2029)
3.3.3 Global Opioids Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Opioids by Application
4.1 Opioids Market Segment by Application
4.1.1 Pain Relief
4.1.2 Anesthesia
4.1.3 Cough Suppression
4.1.4 Diarrhea Suppression
4.1.5 Deaddiction
4.1.6 Others
4.2 Global Opioids Market Size by Application
4.2.1 Global Opioids Market Size Overview by Application (2018-2029)
4.2.2 Global Opioids Historic Market Size Review by Application (2018-2023)
4.2.3 Global Opioids Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioids Sales Breakdown by Application (2018-2023)
4.3.2 Europe Opioids Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Opioids Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Opioids Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Opioids Sales Breakdown by Application (2018-2023)
5 North America Opioids by Country
5.1 North America Opioids Historic Market Size by Country
5.1.1 North America Opioids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Opioids Sales in Volume by Country (2018-2023)
5.1.3 North America Opioids Sales in Value by Country (2018-2023)
5.2 North America Opioids Forecasted Market Size by Country
5.2.1 North America Opioids Sales in Volume by Country (2024-2029)
5.2.2 North America Opioids Sales in Value by Country (2024-2029)
6 Europe Opioids by Country
6.1 Europe Opioids Historic Market Size by Country
6.1.1 Europe Opioids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Opioids Sales in Volume by Country (2018-2023)
6.1.3 Europe Opioids Sales in Value by Country (2018-2023)
6.2 Europe Opioids Forecasted Market Size by Country
6.2.1 Europe Opioids Sales in Volume by Country (2024-2029)
6.2.2 Europe Opioids Sales in Value by Country (2024-2029)
7 Asia-Pacific Opioids by Region
7.1 Asia-Pacific Opioids Historic Market Size by Region
7.1.1 Asia-Pacific Opioids Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Opioids Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Opioids Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Opioids Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioids Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Opioids Sales in Value by Region (2024-2029)
8 Latin America Opioids by Country
8.1 Latin America Opioids Historic Market Size by Country
8.1.1 Latin America Opioids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Opioids Sales in Volume by Country (2018-2023)
8.1.3 Latin America Opioids Sales in Value by Country (2018-2023)
8.2 Latin America Opioids Forecasted Market Size by Country
8.2.1 Latin America Opioids Sales in Volume by Country (2024-2029)
8.2.2 Latin America Opioids Sales in Value by Country (2024-2029)
9 Middle East and Africa Opioids by Country
9.1 Middle East and Africa Opioids Historic Market Size by Country
9.1.1 Middle East and Africa Opioids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Opioids Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Opioids Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Opioids Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioids Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Opioids Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Opioids Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Opioids Products Offered
10.1.5 Teva Recent Development
10.2 Purdue Pharma
10.2.1 Purdue Pharma Company Information
10.2.2 Purdue Pharma Introduction and Business Overview
10.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Purdue Pharma Opioids Products Offered
10.2.5 Purdue Pharma Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mallinckrodt Opioids Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Amneal Pharma
10.4.1 Amneal Pharma Company Information
10.4.2 Amneal Pharma Introduction and Business Overview
10.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Amneal Pharma Opioids Products Offered
10.4.5 Amneal Pharma Recent Development
10.5 Collegium
10.5.1 Collegium Company Information
10.5.2 Collegium Introduction and Business Overview
10.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Collegium Opioids Products Offered
10.5.5 Collegium Recent Development
10.6 J&J
10.6.1 J&J Company Information
10.6.2 J&J Introduction and Business Overview
10.6.3 J&J Opioids Sales, Revenue and Gross Margin (2018-2023)
10.6.4 J&J Opioids Products Offered
10.6.5 J&J Recent Development
10.7 Endo
10.7.1 Endo Company Information
10.7.2 Endo Introduction and Business Overview
10.7.3 Endo Opioids Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Endo Opioids Products Offered
10.7.5 Endo Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Opioids Products Offered
10.8.5 Pfizer Recent Development
10.9 INSYS
10.9.1 INSYS Company Information
10.9.2 INSYS Introduction and Business Overview
10.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2018-2023)
10.9.4 INSYS Opioids Products Offered
10.9.5 INSYS Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mylan Opioids Products Offered
10.10.5 Mylan Recent Development
10.11 Hikma
10.11.1 Hikma Company Information
10.11.2 Hikma Introduction and Business Overview
10.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hikma Opioids Products Offered
10.11.5 Hikma Recent Development
10.12 Egalet
10.12.1 Egalet Company Information
10.12.2 Egalet Introduction and Business Overview
10.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Egalet Opioids Products Offered
10.12.5 Egalet Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioids Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioids Industrial Chain Analysis
11.4 Opioids Market Dynamics
11.4.1 Opioids Industry Trends
11.4.2 Opioids Market Drivers
11.4.3 Opioids Market Challenges
11.4.4 Opioids Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioids Distributors
12.3 Opioids Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
